These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 22457290)
1. Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1. Stegmann KA; Björkström NK; Ciesek S; Lunemann S; Jaroszewicz J; Wiegand J; Malinski P; Dustin LB; Rice CM; Manns MP; Pietschmann T; Cornberg M; Ljunggren HG; Wedemeyer H J Infect Dis; 2012 May; 205(9):1351-62. PubMed ID: 22457290 [TBL] [Abstract][Full Text] [Related]
2. IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells. Zhang S; Saha B; Kodys K; Szabo G J Hepatol; 2013 Sep; 59(3):442-9. PubMed ID: 23665181 [TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection. Stegmann KA; Björkström NK; Veber H; Ciesek S; Riese P; Wiegand J; Hadem J; Suneetha PV; Jaroszewicz J; Wang C; Schlaphoff V; Fytili P; Cornberg M; Manns MP; Geffers R; Pietschmann T; Guzmán CA; Ljunggren HG; Wedemeyer H Gastroenterology; 2010 May; 138(5):1885-97. PubMed ID: 20334827 [TBL] [Abstract][Full Text] [Related]
4. Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells. Yoon JC; Lim JB; Park JH; Lee JM J Virol; 2011 Dec; 85(23):12557-69. PubMed ID: 21937646 [TBL] [Abstract][Full Text] [Related]
5. Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection. Carreca AP; Gaetani M; Busà R; Francipane MG; Gulotta MR; Perricone U; Iannolo G; Russelli G; Carcione C; Conaldi PG; Badami E Viruses; 2022 Jul; 14(7):. PubMed ID: 35891518 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus impairs natural killer cell activity via viral serine protease NS3. Yang CM; Yoon JC; Park JH; Lee JM PLoS One; 2017; 12(4):e0175793. PubMed ID: 28410411 [TBL] [Abstract][Full Text] [Related]
7. CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha. Zhang S; Kodys K; Babcock GJ; Szabo G Hepatology; 2013 Sep; 58(3):940-9. PubMed ID: 22577054 [TBL] [Abstract][Full Text] [Related]
8. Monocytes activate natural killer cells via inflammasome-induced interleukin 18 in response to hepatitis C virus replication. Serti E; Werner JM; Chattergoon M; Cox AL; Lohmann V; Rehermann B Gastroenterology; 2014 Jul; 147(1):209-220.e3. PubMed ID: 24685721 [TBL] [Abstract][Full Text] [Related]
9. HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication. Wang XX; Pan XB; Han JC; Cong X; Jin Q; Kong XS; Wei L; Feng B Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):233-240. PubMed ID: 29625837 [TBL] [Abstract][Full Text] [Related]
11. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects. Papasavvas E; Azzoni L; Yin X; Liu Q; Joseph J; Mackiewicz A; Ross B; Lynn KM; Jacobson JM; Mounzer K; Kostman JR; Montaner LJ J Viral Hepat; 2017 Oct; 24(10):865-876. PubMed ID: 28419653 [TBL] [Abstract][Full Text] [Related]
12. Contradicting roles of miR-182 in both NK cells and their host target hepatocytes in HCV. El Sobky SA; El-Ekiaby NM; Mekky RY; Elemam NM; Mohey Eldin MA; El-Sayed M; Esmat G; Abdelaziz AI Immunol Lett; 2016 Jan; 169():52-60. PubMed ID: 26518141 [TBL] [Abstract][Full Text] [Related]
13. Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment. Bozzano F; Picciotto A; Costa P; Marras F; Fazio V; Hirsch I; Olive D; Moretta L; De Maria A Eur J Immunol; 2011 Oct; 41(10):2905-14. PubMed ID: 21695691 [TBL] [Abstract][Full Text] [Related]
14. Natural killer cells inhibit hepatitis C virus expression. Li Y; Zhang T; Ho C; Orange JS; Douglas SD; Ho WZ J Leukoc Biol; 2004 Dec; 76(6):1171-9. PubMed ID: 15339939 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functions. Holder KA; Stapleton SN; Gallant ME; Russell RS; Grant MD J Immunol; 2013 Sep; 191(6):3308-18. PubMed ID: 23960237 [TBL] [Abstract][Full Text] [Related]
16. An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients. Kokordelis P; Krämer B; Körner C; Boesecke C; Voigt E; Ingiliz P; Glässner A; Eisenhardt M; Wolter F; Kaczmarek D; Nischalke HD; Rockstroh JK; Spengler U; Nattermann J Hepatology; 2014 Mar; 59(3):814-27. PubMed ID: 24382664 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1. Goh CC; Roggerson KM; Lee HC; Golden-Mason L; Rosen HR; Hahn YS J Immunol; 2016 Mar; 196(5):2283-92. PubMed ID: 26826241 [TBL] [Abstract][Full Text] [Related]
18. Functional Behavior of NKp46-Positive Intrahepatic Natural Killer Cells Against Hepatitis C Virus Reinfection After Liver Transplantation. Tanimine N; Tanaka Y; Abe T; Piao J; Chayama K; Ohdan H Transplantation; 2016 Feb; 100(2):355-64. PubMed ID: 26714120 [TBL] [Abstract][Full Text] [Related]
19. [Immunology of HCV infection: the causes of impaired cellular immune response and the effect of antiviral treatment]. Pár G; Berki T; Pálinkás L; Balogh P; Szereday L; Halász M; Szekeres-Barthó J; Miseta A; Hegedus G; Mózsik G; Hunyady B; Pár A Orv Hetil; 2006 Apr; 147(13):591-600. PubMed ID: 16623441 [TBL] [Abstract][Full Text] [Related]
20. NK cells prevalence, subsets and function in viral hepatitis C. Zeromski J; Mozer-Lisewska I; Kaczmarek M; Kowala-Piaskowska A; Sikora J Arch Immunol Ther Exp (Warsz); 2011 Dec; 59(6):449-55. PubMed ID: 21972016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]